Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Tackling Tone in Tiny Tots: Hypertonia Management in Young Children
Joshua A Vova1, Katherine DeGraaff1
1Department of Physical Medicine and Rehabilitation, Children's Healthcare of Atlanta, 1001 Johnson Ferry Road NE, Atlanta, GA 30342, USA.
Insights
Pediatric hypertonia management involves therapy and medications. This review focuses on evidence-based pharmacologic treatments and innovations for children under three years old.
Area of Science:
- Neurology
- Pediatrics
- Pharmacology
Background:
- Hypertonia in young children stems from early brain injuries causing upper motor neuron lesions.
- This leads to muscle tone abnormalities, contractures, and deformities, impacting function.
- Current management combines physical, occupational, and pharmacologic approaches.
Purpose of the Study:
- To review pharmacologic interventions for pediatric hypertonia.
- To provide evidence-based dosing recommendations for young patients.
- To discuss novel innovations in managing pediatric hypertonia.
Main Methods:
- Literature review of existing studies on pharmacologic treatments for hypertonia in children.
- Emphasis on evidence-based dosing and safety in pediatric populations.
- Exploration of emerging treatment strategies and innovations.
Main Results:
- Limited clinical studies exist for pharmacologic treatments in children under three years old.
- Clinicians often rely on off-label prescribing based on experience.
- The review synthesizes available evidence to guide treatment decisions.
Conclusions:
- Multifaceted management is crucial for pediatric hypertonia.
- Further research is needed for evidence-based pharmacologic guidelines in very young children.
- Innovations offer potential for improved outcomes in managing pediatric hypertonia.
Abstract:
In young children, hypertonia results from early brain insults leading to upper motor neuron lesions, which cause changes in muscle tone and pathology. These changes contribute to contractures and deformities that impair activity and participation. The management of hypertonia requires a multifaceted approach, combining phyisical and occupational therapy and pharmacologic interventions. However, limited clinical studies exist for pharmacologic treatments in children aged under 3 years, leaving clinicians to rely on experience when prescribing off-label medications. This article reviews the pharmacologic interventions for hypertonia, with an emphasis on evidence-based dosing recommendations in pediatric patients and new innovations for the management of pediatric hypertonia.
Related Concept Videos
Hypertension V: Nursing Management
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Tonsillitis II: Management
Asthma-IV: Nursing Management
First, in...
Skeletal Muscle Relaxants: Therapeutic Uses
Mitral Stenosis IV: Nursing Management

